1. Home
  2. EPM vs GBIO Comparison

EPM vs GBIO Comparison

Compare EPM & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$3.63

Market Cap

124.2M

Sector

Energy

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.45

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
GBIO
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.2M
36.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EPM
GBIO
Price
$3.63
$5.45
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$4.93
$8.88
AVG Volume (30 Days)
518.0K
69.2K
Earning Date
02-10-2026
11-05-2025
Dividend Yield
13.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$85,232,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$3.00
52 Week High
$5.70
$12.40

Technical Indicators

Market Signals
Indicator
EPM
GBIO
Relative Strength Index (RSI) 37.48 49.21
Support Level $3.54 $5.40
Resistance Level $3.66 $5.77
Average True Range (ATR) 0.11 0.22
MACD 0.00 0.02
Stochastic Oscillator 17.50 43.85

Price Performance

Historical Comparison
EPM
GBIO

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: